 AUSTIN, Texas--BUSINESS WIRE--Savara Inc. Nasdaq: SVRA, a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will present at the H.C. Wainwright BIOCONNECT Virtual Conference being held January 10-13, 2022. A webcast of the presentation will be available at 7:00 AM ET4:00 AM PT on January 10, 2022 on Savaras website at and archived for 90 days. About Savara Savara is a 